OR14 Disorders of Phosphate Metabolism and Metabolic Bone Disease

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Bone, Calciotropic Hormones & Vitamin D-Translational
Saturday, April 2, 2016: 11:45 AM-1:15 PM
Room 104 (BCEC)
Chairs:
David R Weber, MD, MSCE, University of Rochester, Rochester, NY and Henry G Bone III, MD, Michigan Bone and Mineral Clinic, Detroit, MI

Disclosures:
HGB III: Speaker, Research Support / Speaker Fees, Investigator, Speaker Fees, Investigator, Consulting Fees, Consultant, Grunenthal. Nothing to Disclose: DRW Disclosure Not Provided: RE
11:45 AM
Natalia Campos-Obando1, Lies Lahousse2, Guy G Brusselle2, Bruno H Stricker3, Albert Hofman3, Henning Tiemeier4, Oscar H Franco5, Andre G Uitterlinden6, Andre G Uitterlinden6 and M. Carola Zillikens6, (1)Internal Medicine, Erasmus Medical Center
(2)Department of Respiratory Medicine, Ghent University Hospital
(3)Epidemiology, Erasmus Medical Center
(4)Dept. of epidemiology, Erasmus Medical Center, Rotterdam
(5)Epidemiology, Erasmus MC, Rotterdam
(6)Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands
12:00 PM
Voraluck Phatarakijnirund1, Gary S Gottesman, MD2, Katherine L Madson3, William H Mcalister, MD4, Fan Zhang, MD2, Valerie Wollberg, RN2 and Michael P Whyte, MD5, (1)Medicine, Washington University School of Medicine in St.louis, St. louis, MO
(2)Shriners Hospitals for Children - St. Louis
(3)Shriners Hospitals for Children, St. Louis, MO
(4)Washington University School of Medicine
(5)Center for Metabolic Bone Disease and Molecular Research, Shriners Hosp for Children, Saint Louis, MO
12:15 PM
Thomas O Carpenter, MD1, Erik Imel, MD2, Annemieke Boot, MD3, Wolfgang Högler, MD4, Agnes Linglart, MD5, Raja Padidela, MD6, William van't Hoff, MD7, Michael P Whyte, MD8, Yi Zhou, PhD9, Alison Skrinar, PhD9, Javier San Martin, MD9 and Anthony A Portale, MD10, (1)Pediatrics (Endocrinology), Yale University School of Medicine, New Haven, CT
(2)Indiana University School of Medicine, Indianapolis, IN
(3)University of Groningen, Groningen, Netherlands
(4)Birmingham Children's Hospital, Birmingham, United Kingdom
(5)APHP, Reference center for rare disorders of the mineral metabolism and Plateforme d’expertise Paris Sud Maladies Rares, Le Kremlin Bicêtre, Paris, France
(6)Department of Paediatric Endocrinology, Manchester Royal Children's Hospital, Manchester, United Kingdom
(7)Great Ormond Street Hospital, London, United Kingdom
(8)Shriners Hospitals for Children, St. Louis, MO
(9)Ultragenyx Pharmaceutical Inc., Novato, CA
(10)University of CA - San Francisco, San Francisco, CA
12:30 PM
Supriya Kulkarni, Fellow in Endocrinology, Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, NE, Elizabeth Bell, School of Medicine, Creighton University, Omaha, NE and Laura Anne Graeff Armas, MD, MS, Endocrinology, Diabetes and Metabolism, University of Nebraska Medical Center, Omaha, NE
12:45 PM
Elena Gonzalez Rodriguez1, Olivier Lamy1, Delphine Stoll1, Martin Preisig2, Peter Vollenweider3, Pedro Marques-Vidal4, Gerard Waeber3, Bérengère Aubry-Rozier1 and Didier Hans1, (1)Center of Bone Diseases, Lausanne University Hospital, Lausanne, Switzerland
(2)Epidemiology and Psychopathology Research Unit, University Hospital of Lausanne, Lausanne, Switzerland
(3)Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland
(4)Institut of Social and Preventative Medicine, Lausanne University Hospital, Lausanne, Switzerland
1:00 PM
Shilpi Singh, MBBS, MPH, Endocrinology, Creighton University Medical Center, omaha, NE, J Christopher Gallagher, MD, Dept of Endo, Creighton University Medical Cen, Omaha, NE and Lynette M Smith, Biostatistics, Public health, University of Nebraska Medical Center, Omaha, NE

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire